Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Cyclopharm Ltd

CYC
Current price
1.38 AUD -0.01 AUD (-0.72%)
Last closed 1.35 AUD
ISIN AU000000CYC5
Sector Healthcare
Industry Medical Devices
Exchange Australian Securities Exchange
Capitalization 152 926 704 AUD
Yield for 12 month -35.21 %
1Y
3Y
5Y
10Y
15Y
CYC
21.11.2021 - 28.11.2021

Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, and internationally. The company operates through Technegas and Molecular Imaging segments. The Technegas segment offers diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism. This segment also distributes products to the diagnostic imaging sector. The Molecular Imaging segment provides radiopharmaceuticals that are used by physicians in the detection of cancer, neurological disorders, and cardiac diseases. The company serves nuclear medicine departments. Cyclopharm Limited was founded in 1986 and is headquartered in Kingsgrove, Australia. Address: 1 The Crescent, Kingsgrove, NSW, Australia, 2208

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

4.19 AUD

P/E ratio

Dividend Yield

Current Year

+27 662 643 AUD

Last Year

+23 666 311 AUD

Current Quarter

+12 511 233 AUD

Last Quarter

+10 821 138 AUD

Current Year

+4 584 008 AUD

Last Year

+6 054 521 AUD

Current Quarter

-1 578 117 AUD

Last Quarter

-948 646 AUD

Key Figures CYC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -13 227 508 AUD
Operating Margin TTM -56.51 %
PE Ratio
Return On Assets TTM -15.37 %
PEG Ratio
Return On Equity TTM -22.59 %
Wall Street Target Price 4.19 AUD
Revenue TTM 24 519 308 AUD
Book Value 0.44 AUD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -18.9 %
Dividend Yield
Gross Profit TTM 17 749 680 AUD
Earnings per share -0.1 AUD
Diluted Eps TTM -0.1 AUD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY -83.3 %
Profit Margin -38.72 %

Dividend Analytics CYC

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

-18 %

Dividend History CYC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date 01.09.2023
Forward Annual Dividend Yield
Last Split Factor 1:5
Payout Ratio 66.23 %
Last Split Date 28.05.2012
Dividend Date

Stock Valuation CYC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 116.2791
Enterprise Value Revenue 5.6015
Price Sales TTM 6.237
Enterprise Value EBITDA -24.5712
Price Book MRQ 3.2021

Financials CYC

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators CYC

For 52 weeks

1.38 AUD 2.24 AUD
50 Day MA 1.54 AUD
Shares Short Prior Month
200 Day MA 1.65 AUD
Short Ratio
Shares Short
Short Percent